OFF-BRAND STI571: A COST-EFFECTIVE OPTION?

The arrival of common imatinib represents a significant possibility for patients battling a certain type of cancer and other illnesses. Original brand-name imatinib, branded as Gleevec, carries a considerable price label, frequently presenting a challenge for accessibility for some individuals. O